These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15743510)

  • 21. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
    Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
    [No Abstract]   [Full Text] [Related]  

  • 22. Endocrine therapy for early breast cancer.
    Hussain SA; Williams S; Stevens A; Rea DW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
    Monnier A
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1355-9. PubMed ID: 17069521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Timing of radiotherapy in the treatment of breast carcinoma. Review of the literature].
    Trovò MG; Gigante M; Roncadin M; Arcicasa M; Bortolus R
    Ann Ital Chir; 1999; 70(3):371-6. PubMed ID: 10466240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug therapy of breast carcinoma].
    Dittrich C
    Wien Med Wochenschr; 2000; 150(4):72-86. PubMed ID: 10829307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer.
    Donegan WL
    Can J Surg; 1992 Aug; 35(4):371-7. PubMed ID: 1498737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy for pancreas cancer: advances and controversies.
    Mulcahy MF
    Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
    Alvarez RH; Booser DJ; Cristofanilli M; Sahin AA; Strom EA; Guerra L; Kau SW; Gonzalez-Angulo AM; Hortobagyi GN; Valero V
    Cancer; 2010 Mar; 116(5):1210-7. PubMed ID: 20082452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of definitive radiation therapy for primary breast cancer on ability to deliver adjuvant chemotherapy.
    Lippman ME; Edwards BK; Findlay P; Danforth DW; MacDonald H; D'Angelo T; Gorrell C
    NCI Monogr; 1986; (1):99-104. PubMed ID: 3534597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
    Burstein HJ; Bellon JR; Galper S; Lu HM; Kuter I; Taghian AG; Wong J; Gelman R; Bunnell CA; Parker LM; Garber JE; Winer EP; Harris JR; Powell SN
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):496-504. PubMed ID: 16243442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New methods in the treatment of breast cancer].
    Semiglazov VF
    Vopr Onkol; 1997; 43(1):22-6. PubMed ID: 9133082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving concepts in the systemic adjuvant treatment of breast cancer.
    Bonadonna G
    Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adjuvant for breast cancer chemo-endocrine therapy].
    Taguchi T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):453-67. PubMed ID: 9530350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herceptin in early breast cancer: a call for judicious use.
    Thorat MA
    Natl Med J India; 2005; 18(6):315-7. PubMed ID: 16483033
    [No Abstract]   [Full Text] [Related]  

  • 38. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subclinical heart damage caused by adjuvant anthracycline chemotherapy].
    Dunst J
    Strahlenther Onkol; 2002 Feb; 178(2):110-1. PubMed ID: 11942035
    [No Abstract]   [Full Text] [Related]  

  • 40. [Breast cancer].
    Ikeda T; Jinno H; Matsui A; Mitsui Y; Asaga S; Muto T; Wada M; Kitajima M
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1509-15. PubMed ID: 12355936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.